Key result
Downregulating miR-124 reduces infarct area and improves cardiac function in MI mice by upregulating STAT3.
Why the study?
The biological functions of microRNA-124 in cardiomyocytes and its role in myocardial infarction-induced cardiac injury were not well understood.
Does silencing miR-124 reduce cardiomyocyte apoptosis and improve cardiac function in preclinical models of myocardial infarction?
Does silencing miR-124 reduce cardiomyocyte apoptosis and improve cardiac function in preclinical models of myocardial infarction?
Downregulation of miR-124 inhibits myocardial infarction-induced apoptosis through upregulating STAT3, suggesting a potential therapeutic target for myocardial infarction.
Answers are grounded in this paper and cite their sources.
miR-124 inhibition may attenuate experimental MI injury; hypothesis-generating for STAT3-targeted therapies, requiring clinical validation.
BACKGROUND/AIMS: MicroRNAs play an important role in regulating myocardial infarction (MI)-induced cardiac injury. MicroRNA-124 (miR-124) plays a vital role in regulating cellular proliferation, differentiation and apoptosis. Although the alteration of miR-124 was confirmed in peripheral blood of MI patients, little is known regarding the biological functions of miR-124 in cardiomyocytes. This study was designed to explore the role of miR-124 in MI and its underlying mechanisms. METHODS: Real-time PCR was used to quantify the microRNAs levels. TUNEL and Flow cytometry were performed to measure cell apoptosis. Western blot analysis was employed to detect expression of Bcl-2, Bax, Caspase-3 and STAT3 proteins. RESULTS: We revealed that miR-124 was significantly up-regulated in a mice model of MI and in neonatal rat ventricular myocytes (NRVMs) with H2O2 treatment. H2O2 treatment induced cardiomyocyte injury with reduced cell viability and enhanced apoptotic cell death, whereas silencing expression of miR-124 by AMO-124 (antisense inhibitor oligodeoxyribonucleotides) alleviated these deleterious changes. AMO-124 decreased the expression of Bax and cleaved-caspase-3 and upregulated the expression of Bcl-2 in H2O2-treated NRVMs. Besides, AMO-124 improved mitochondrial dysfunction of NRVMs induced by H2O2 treatment. Moreover, antagomir-124 markedly decreased the infarct area and apoptotic cardiomyocytes and improved cardiac function in MI mice. Furthermore, we identified STAT3 as a direct target of miR-124, and downregulation of miR-124 ameliorated the diminished levels of STAT3 and p-STAT3 (Tyr705) in response to H2O2 or MI. STAT3 inhibitor, stattic, was shown to attenuate the elevation of p-STAT3 in NRVMs with AMO-124 transfection. Inhibiting of STAT3 activity by stattic abrogated protective effects of AMO-124 on H2O2-induced cardiomyocytes apoptosis. CONCLUSION: Taken together, our data demonstrate that downregulation of miR-124 inhibits MI-induced apoptosis through upregulating STAT3, which suggests the therapeutic potential of miR-124 for myocardial infarction.
No takes yet. Share an insight, caveat, or question.
He et al. (2018) studied Myocardial infarction. AMO-124 (antisense inhibitor oligodeoxyribonucleotides) / antagomir-124 vs. Control / H2O2 treatment / MI without inhibitor was evaluated on Cardiomyocyte apoptosis and infarct area. Downregulation of miR-124 by AMO-124 or antagomir-124 decreased infarct area, reduced cardiomyocyte apoptosis, and improved cardiac function in MI mice by upregulating STAT3.
Synapse has enriched 10 related papers. Consider them for comparative context: